Table 2.
Descriptive outcome measures for the REMOTE-CR (intervention) and centre-based (control) programmes
| REMOTE-CR (mean±SD) | Centre-based (mean±SD) | |||||
| Baseline | Week 12 | Week 24 | Baseline | Week 12 | Week 24 | |
| V̇O2max (mL/kg/min) | 27.22±7.91 | 30.52±9.63 | – | 27.70±6.77 | 29.39±6.75 | – |
| Physical activity (min/day)* | ||||||
| Sedentary | 596.8±120.1 | 596.4±110.9 | 595.9±94.9 | 591.0±124.2 | 604.2±143.8 | 659.6±181.9 |
| Light | 256.7±67 | 258.3±65.2 | 253.9±51.4 | 260.5±65.6 | 287.0±74.2 | 270.5±68.3 |
| Moderate | 24.6±20.6 | 25.3±17.6 | 23.0±15.8 | 24.3±16.3 | 30.6±18.4 | 23.3±16.0 |
| Vigorous | 0.4±1.3 | 1.4±3.9 | 1.3±4.3 | 0.3±1.8 | 0.8±3.3 | 1.2±4.0 |
| Body composition | ||||||
| Body mass (kg) | 85.83±15.83 | 85.73±14.59 | 86.49±15.35 | 83.06±14.96 | 82.08±14.2 | 82.94±14.73 |
| BMI (kg/m2) | 29.09±4.59 | 29.03±4.32 | 29.13±4.50 | 27.94±3.49 | 27.58±3.34 | 27.90±3.44 |
| Waist (cm) | 103.30±10.97 | 103.20±10.82 | 102.90±11.10 | 101.50±9.99 | 99.60±10.11 | 101.10±10.11 |
| Hip (cm) | 106.00±8.59 | 106.00±8.22 | 105.80±8.19 | 103.60±6.68 | 102.30±6.34 | 103.70±6.83 |
| Blood pressure (mm Hg) | ||||||
| Systolic | 139.00±17.38 | 135.60±16.66 | 135.4±18.17 | 134.40±17.00 | 130.50±15.14 | 132.70±17.42 |
| Diastolic | 80.90±10.84 | 78.04±9.04 | 79.18±10.50 | 79.83±10.17 | 78.11±10.83 | 77.76±10.79 |
| Blood lipids (mmol/L) | ||||||
| Total-C | 3.39±0.79 | 3.62±0.98 | – | 3.45±0.79 | 3.55±0.92 | – |
| LDL-C | 1.80±0.69 | 1.95±0.97 | – | 1.68±0.58 | 1.71±0.59 | – |
| HDL-C | 1.05±0.37 | 1.15±0.40 | – | 1.09±0.37 | 1.13±0.37 | – |
| Triglyceride | 1.46±0.89 | 1.48±0.81 | – | 1.68±1.08 | 1.66±1.11 | – |
| Blood glucose (mmol/L) | 5.44±1.9 | 5.87±1.61 | – | 5.49±1.51 | 6.07±2.35 | – |
| HRQoL | ||||||
| EQ-5D index | 0.91±0.10 | 0.90±0.13 | 0.89±0.13 | 0.91±0.10 | 0.93±0.09 | 0.92±0.09 |
| Health state (%) | 68.95±18.56 | 77.24±14.23 | 78.84±16.19 | 71.16±19.26 | 81.21±12.42 | 81.28±13.76 |
| Exercise motivation | ||||||
| Task self-efficacy (%) | 63.44±21.90 | 79.48±18.26 | 72.45±21.64 | 70.56±15.51 | 80.09±14.04 | 78.14±17.79 |
| Barrier self-efficacy (%) | 75.52±18.79 | 75.06±20.04 | 71.05±22.79 | 80.72±15.45 | 81.09±15.37 | 77.54±19.3 |
| Confidence to adhere (%) | 91.92±14.58 | 91.50±13.87 | 83.42±22.19 | 83.42±22.19 | 89.65±15.65 | 88.79±18.41 |
| Intention† | 6.73±0.52 | 6.53±0.98 | 6.25±1.01 | 6.81±0.71 | 6.60±0.83 | 6.53±0.91 |
| Locus of causality† | 4.13±1.64 | 4.08±1.76 | 4.23±1.69 | 4.38±1.73 | 4.31±1.58 | 4.30±1.53 |
| Exercise adherence (n/36) | – | 21±13 | – | – | 23±11 | – |
*Objective accelerometry.
†Seven-point Likert scale.
BMI, body mass index; EQ-5D, EuroQol 5-dimension; HDL-C, high-density lipoprotein cholesterol; HRQoL, health-related quality of life; LDL-C, low-density lipoprotein cholesterol; REMOTE-CR, remotely monitored exercise-based cardiac telerehabilitation; total-C, total cholesterol; V̇O2max, maximal aerobic exercise capacity.